Adaptive by Design:
How RTSM Powers Early-Phase Clinical Trial Success

Date
Thursday, May 01, 2025Thu, May 1, 2025
Duration
60 min
Ready On-Demand
Free — start watching in secondsFree

About this webinar

Early-phase clinical trials require precision and agility. Yet, managing protocol changes, patient cohorts and investigational product (IP) supply can quickly become a logistical challenge.

Adaptive trials require faster decision-making and seamless execution. Without the right randomization and trial supply management (RTSM), teams jeopardize both study success and patient safety.

The key to overcoming these challenges is not just automation—it is adaptability. A configurable RTSM evolves with your trial to mitigate risk, improve compliance and prevent costly supply disruptions. When integrated with an eClinical platform, RTSM enhances workflows and efficiency, ensuring trials stay on track.

This webinar explores why a flexible RTSM is essential for early-phase success—and how Medrio’s unified approach makes a difference.

Register for this webinar today to learn how a unified, configurable RTSM solution can drive early-phase trial success.

Who should attend

This webinar will appeal to:
  • Sponsors and CRO Professionals
  • Clinical Operations Leaders/Trial Managers
  • RTSM/Clinical Supply Chain Decision-Makers
  • Regulatory/Compliance Specialists

What you will learn

Attendees will learn about:
  • Why adaptability is critical in early-phase trials and how traditional approaches create inefficiencies
  • How RTSM plays a direct role in patient safety by enabling real-time adjustments to cohorts, dose escalation and supply management
  • How automation reduces risk, improves compliance and streamlines trial execution
  • Why an integrated RTSM and eClinical platform provides greater efficiency and oversight

Featured Speakers

Ian Davison, RTSM Subject Matter Expert, Medrio

Ian Davison

RTSM Subject Matter Expert · Medrio

Ian Davison brings 25 years of experience in clinical trial technology. His background specializes in IVR/IWR/RTSM design and implementation, supply chain management, trial status reporting and subject management. He is also an expert in supply chain optimization, ensuring on-time delivery of investigational products (IPs) with full product accountability.

With experience managing a wide range of clients, Ian enjoys using his knowledge in business process analysis, system development and project management to develop efficient and effective clinical trial control systems.

Naji Hamim, RTSM Product Owner, Medrio

Naji Hamim

RTSM Product Owner · Medrio

Naji Hamim is a product leader with over five years of experience driving innovation in clinical trial technology. As the RTSM Product Owner at Medrio, he focuses on developing flexible, user-driven solutions that improve trial efficiency and streamline research workflows.

Passionate about leveraging technology to accelerate drug development and enhance the clinical trial experience, Naji collaborates with sponsors and CROs to optimize randomization, supply management and study execution while ensuring greater flexibility and control in trial operations.

Partner for this event

Medrio

Trusted by sponsors, CROs and sites worldwide, Medrio aims to improve 100 million lives through faster, more efficient, and secure clinical trials. With almost two decades of experience, Medrio delivers proven, scalable solutions, unrivaled customer support, and guidance to the industry’s leading innovators, including pharmaceutical, biotech, medical device, diagnostics and more. The company’s suite of solutions, including CDMS/EDC, eCOA/ePRO, eConsent and RTSM, enables the capture of quality clinical trial data while optimizing workflows for regulatory readiness. Experience the power of Medrio and realize the full potential of your clinical operations and outcomes – visit www.medrio.com.

Explore more webinars

Pick a topic to browse every free webinar in the Xtalks library on that subject.

Not what you're looking for? Browse all webinars →

On-demand webinar